MyFinsight
Home
Blog
About
Cash and cash
equivalents
$33,993,982
(207.89%↑ Y/Y)
Prepaid expenses and
other current assets
$883,659
(-43.95%↓ Y/Y)
Total current assets
$34,877,641
(176.42%↑ Y/Y)
Operating lease
right-of-use asset
$1,433,706
(258.20%↑ Y/Y)
Property, plant &
equipment, net
$304,173
(-53.03%↓ Y/Y)
Other long-term
assets
$23,566
(-20.87%↓ Y/Y)
Total assets
$36,639,086
(167.53%↑ Y/Y)
Total liabilities and
stockholders' equity
$36,639,086
(167.53%↑ Y/Y)
Total stockholders'
equity
$29,871,833
(390.91%↑ Y/Y)
Total liabilities
$6,767,253
(8.66%↑ Y/Y)
Accumulated deficit
-$281,718,099
(-8.61%↓ Y/Y)
Additional paid-in capital
$311,589,849
(17.60%↑ Y/Y)
Total current
liabilities
$5,237,711
(-10.72%↓ Y/Y)
Lease liability, net
of current portion
$1,529,542
(323.13%↑ Y/Y)
Common stock, 0.00001
par value...
$83
(361.11%↑ Y/Y)
Accounts payable and
accrued liabilities
$5,218,681
(11.54%↑ Y/Y)
Warrant liability
$17,000
(-98.45%↓ Y/Y)
Lease liability,
current
$2,030
(-97.79%↓ Y/Y)
Back
Back
Balance Sheet
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)
source: myfinsight.com